0001014108-26-000021.txt : 20260408 0001014108-26-000021.hdr.sgml : 20260408 20260408155617 ACCESSION NUMBER: 0001014108-26-000021 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260408 DATE AS OF CHANGE: 20260408 EFFECTIVENESS DATE: 20260408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bond Biosciences, Inc. CENTRAL INDEX KEY: 0001824224 ORGANIZATION NAME: EIN: 810933527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-579597 FILM NUMBER: 26848028 BUSINESS ADDRESS: STREET 1: 555 MADISON AVENUE STREET 2: SUITE 1201 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 650-804-2139 MAIL ADDRESS: STREET 1: 555 MADISON AVENUE STREET 2: SUITE 1201 CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0708 D LIVE 0001824224 Bond Biosciences, Inc. 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 650-804-2139 DELAWARE None None Corporation true Michael Beckloff 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Director Cory Berkland 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Executive Officer Director Timothy Opler 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Director Michael A. Riley 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Executive Officer Director Other Health Care Decline to Disclose 06b false 2026-04-01 false true false 0 Collage Venture Partners, LLC 316063 Stonehaven, LLC 118913 929 Alton Road Suite 500 Miami Beach FL FLORIDA 33139 All States true 15000000 5342880 9657120 false 64 364270 0 0 false Bond Biosciences, Inc. /s/Michael A. Riley Michael A. Riley Chief Executive Officer 2026-04-08